Peter Monteleone, MD
Interventional Cardiology · Kyle, TXNPI 1164625760
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Boston Scientific at 58.0% of the total. Among interventional cardiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 706 payments — averaging $653.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$268K
- Medtronic$145K
- Inquis Medical, Inc.$10K
- Surmodics, Inc.$7K
- Heartflow, Inc.$6K
- Penumbra, Inc.$4K
- plus $21K from 31 others
Across 572 payments — averaging $1285.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$319K
- Medtronic$154K
- Inspiremd Ltd$65K
- Biotronik Inc.$52K
- Amgen$45K
- Veryan Medical Incorporated$42K
- plus $59K from 4 others
What the payments were for
- Consulting fees$130,39628%
- Speaking & faculty fees$265,70558%
- Grants$3000%
- Travel & lodging$32,7057%
- Food & beverage$32,2837%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 295 | $267,733 |
| Medtronic(2 entities) | 228 | $145,124 |
| Inquis Medical, Inc. | 4 | $10,114 |
| Surmodics, Inc. | 8 | $7,100 |
| Heartflow, Inc. | 20 | $6,484 |
| Penumbra, Inc. | 5 | $4,318 |
| Biotronik Inc. | 21 | $4,260 |
| Abbott | 24 | $4,085 |
| Angiodynamics, Inc. | 5 | $3,169 |
| Amgen | 8 | $1,714 |
| Abiomed | 25 | $1,192 |
| Inari Medical, Inc. | 10 | $1,136 |
| Premier Healthcare Solutions, Inc. | 2 | $1,000 |
| Silk Road Medical, Inc. | 1 | $700 |
| Inspiremd Ltd | 2 | $631 |
| Cardiovascular Systems Inc. | 13 | $599 |
| Shockwave Medical, Inc | 6 | $567 |
| Edwards Lifesciences | 2 | $138 |
| Cvrx, Inc. | 1 | $133 |
| Stryker | 3 | $131 |
| Terumo Medical Corporation | 4 | $129 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $118 |
| Flowphysix Inc | 2 | $109 |
| Cook Medical LLC | 1 | $104 |
| Impulse Dynamics (USA) Inc. | 1 | $103 |
| Contego Medical, Inc | 1 | $91 |
| Pfizer | 1 | $81 |
| Veryan Medical Incorporated | 1 | $73 |
| Asahi Intecc USA, Inc. | 1 | $65 |
| Boehringer Ingelheim | 3 | $47 |
| Cardiva Medical, Inc. | 1 | $23 |
| Siemens Medical Solutions USA, Inc. | 1 | $22 |
| Getinge USA Sales, LLC | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EKOSONIC$140,702
- HawkOne$60,869
- GENERAL - THERAPIES$54,497
- IN.PACT Admiral$29,569
- TurboHawk$18,719
- AngioJet Ultra 5000A$12,249
- FlowMet-R$10,321
- Aventus$10,000
- Pounce Thrombectomy$6,941
- Pounce Venous Thrombectomy System$6,941
- Pounce Thrombectomy System$6,750
- PROWL Registry$6,750
- Pounce XL Thrombectomy$6,750
- FFRct$5,633
- CHOCOLATE PTA BALLOON CATHETER$5,200
- GENERAL THROMBECTOMY$4,558
- Indigo System$4,262
- FlowMet$4,000
- QT Vascular Chocolate PTA Balloon$3,400
- AlphaVac$3,142
How this compares
$461,389 in reported general payments places this provider in the 95th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 99 | $87,868 |
| Repatha SureclickEvolocumab | 43 | $44,279 |
| EntrestoSacubitril/Valsartan | 13 | $24,747 |
| XareltoRivaroxaban | 17 | $23,838 |
| Rosuvastatin Calcium | 239 | $2,021 |
| Atorvastatin Calcium | 185 | $1,716 |
| Metoprolol Succinate | 134 | $1,624 |
| Ezetimibe | 48 | $1,395 |
| Nitroglycerin | 71 | $1,071 |
| Carvedilol | 137 | $1,011 |
| Amlodipine Besylate | 97 | $827 |
| Lisinopril | 122 | $782 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 63 | $738 |
| Losartan Potassium | 46 | $593 |
| ClopidogrelClopidogrel Bisulfate | 64 | $402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $81 | $87,86899 claims |
| Johnson & JohnsonXarelto | $17 | $23,83817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 686 interventional cardiology providers in Texas.
Other interventional cardiology in Kyle
- Vamsi KrishnaKyle$2M
- Juan GranadaHouston$4.1M
- Jeffrey CarrTyler$1.9M
- John IsaacHouston$1.8M
- Robert ChiltonSan Antonio$1.3M
- Sameh SayfoPlano$1M
- Srinivasa PotluriPlano$781K
- Karim Al-AziziPlano$734K
- Robert StolerDallas$587K
- Francis ZidarAustin$433K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.